Novo Holdings A/S

SEC Form 4 insider trading activity

Novo Holdings A/S has filed 3 SEC Form 4 filings (5 transaction rows) across 3 companies, including COAG, AVLN, MPLT, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 6, 2026.

On the most recent filing, Novo Holdings A/S is listed as 10% Owner at Avalyn Pharma Inc. Inside the rolling window, Novo Holdings A/S reported 2 open-market purchases totaling $26.2M in AVLN and MPLT and no open-market sales. The largest disclosed transaction in the window is a purchase of 952,941 MPLT shares on Oct 28, 2025, worth $16.2M.

Companies traded

Other insiders at COAG

Insider Buying

$26.2M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

3

in the rolling window

Source
AVLN
Novo Holdings A/S
Purchase$10.0MMay 5SEC ↗
MPLT
Novo Holdings A/S
Purchase$16.2MOct 30SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Novo Holdings A/S made?

Novo Holdings A/S has filed 3 SEC Form 4 filings (5 transaction rows) across 3 companies, including COAG, AVLN, MPLT since 2025.

Which companies does Novo Holdings A/S trade?

Novo Holdings A/S has filed SEC Form 4 disclosures for 3 companies, including COAG, AVLN, MPLT.

When was Novo Holdings A/S's most recent SEC Form 4 filing?

Novo Holdings A/S's most recent SEC Form 4 filing on Tracefour is dated May 6, 2026.

What is Novo Holdings A/S's total buy and sell value in the current window?

Inside the rolling retention window, Novo Holdings A/S bought $26.2M and sold $0 based on SEC Form 4 filings.

What was Novo Holdings A/S's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 952,941 MPLT shares on 2025-10-28, worth $16.2M, per SEC Form 4 filings.